Insiders · Profile

Simon Farrell

Chief Commercial Officer at Trevi Therapeutics. Filing since 10 Mar 2025. CIK 0001965585

Company

Date

Role

Action

Amount

Of holding

10 Mar 2025

Chief Commercial Officer

Sold on a plan

81,313

$548.88K

51.4%

1 decision on file.